Advertisement

Role of Electrical Delay in Cardiac Resynchronization Therapy Response

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abraham W.T.
        • Fisher W.G.
        • Smith A.L.
        • et al.
        Cardiac resynchronization in chronic heart failure.
        N Engl J Med. 2002; 346: 1845-1853
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • et al.
        Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350: 2140-2150
        • Cazeau S.
        • Leclercq C.
        • Lavergne T.
        • et al.
        Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
        N Engl J Med. 2001; 344: 873-880
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • et al.
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352: 1539-1549
        • Gold M.R.
        • Rickard J.
        • Daubert J.C.
        • et al.
        Redefining the classifications of response to cardiac resynchronization therapy: results from the REVERSE study.
        JACC Clin Electrophysiol. 2021; 7: 871-880
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361: 1329-1338
        • Ypenburg C.
        • van Bommel R.J.
        • Borleffs C.J.
        • et al.
        Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
        J Am Coll Cardiol. 2009; 53: 483-490
        • Linde C.
        • Abraham W.T.
        • Gold M.R.
        • et al.
        Predictors of short-term clinical response to cardiac resynchronization therapy.
        Eur J Heart Fail. 2017; 19: 1056-1063
        • Rickard J.
        • Michtalik H.
        • Sharma R.
        • et al.
        Predictors of response to cardiac resynchronization therapy: a systematic review.
        Int J Cardiol. 2016; 225: 345-352
        • Butter C.
        • Auricchio A.
        • Stellbrink C.
        • et al.
        Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients.
        Circulation. 2001; 104: 3026-3029
        • Singh J.P.
        • Klein H.U.
        • Huang D.T.
        • et al.
        Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.
        Circulation. 2011; 123: 1159-1166
        • Thebault C.
        • Donal E.
        • Meunier C.
        • et al.
        Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
        Eur Heart J. 2012; 33: 2662-2671
        • Saxon L.A.
        • Olshansky B.
        • Volosin K.
        • et al.
        Influence of left ventricular lead location on outcomes in the COMPANION study.
        J Cardiovasc Electrophysiol. 2009; 20: 764-768
        • Bleeker G.B.
        • Kaandorp T.A.
        • Lamb H.J.
        • et al.
        Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.
        Circulation. 2006; 113: 969-976
        • Ypenburg C.
        • van Bommel R.J.
        • Delgado V.
        • et al.
        Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.
        J Am Coll Cardiol. 2008; 52: 1402-1409
        • Khan F.Z.
        • Virdee M.S.
        • Palmer C.R.
        • et al.
        Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
        J Am Coll Cardiol. 2012; 59: 1509-1518
        • Saba S.
        • Marek J.
        • Schwartzman D.
        • et al.
        Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.
        Circ Heart Fail. 2013; 6: 427-434
        • Singh J.P.
        • Fan D.
        • Heist E.K.
        • et al.
        Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.
        Heart Rhythm. 2006; 3: 1285-1292
        • Writing Group M.
        • Tracy C.M.
        • Epstein A.E.
        • et al.
        2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Thorac Cardiovasc Surg. 2012; 144: e127-e145
        • Yu C.M.
        • Sanderson J.E.
        • Marwick T.H.
        • et al.
        Tissue Doppler imaging a new prognosticator for cardiovascular diseases.
        J Am Coll Cardiol. 2007; 49: 1903-1914
        • Ruschitzka F.
        • Abraham W.T.
        • Singh J.P.
        • et al.
        Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.
        N Engl J Med. 2013; 369: 1395-1405
        • Hara H.
        • Oyenuga O.A.
        • Tanaka H.
        • et al.
        The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy.
        Eur Heart J. 2012; 33: 2680-2691
        • Gold M.R.
        • Birgersdotter-Green U.
        • Singh J.P.
        • et al.
        The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.
        Eur Heart J. 2011; 32: 2516-2524
        • Gold M.R.
        • Yu Y.
        • Wold N.
        • et al.
        The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.
        Heart Rhythm. 2017; 14: 1748-1755
        • Field M.E.
        • Yu N.
        • Wold N.
        • et al.
        Comparison of measures of ventricular delay on cardiac resynchronization therapy response.
        Heart Rhythm. 2020; 17: 615-620
        • Sassone B.
        • Gabrieli L.
        • Saccà S.
        • et al.
        Value of right ventricular-left ventricular interlead electrical delay to predict reverse remodelling in cardiac resynchronization therapy: the INTER-V pilot study.
        Europace. 2010; 12: 78-83
        • Kass D.A.
        An epidemic of dyssynchrony: but what does it mean?.
        J Am Coll Cardiol. 2008; 51: 12-17
        • Mafi-Rad M.
        • Van't Sant J.
        • Blaauw Y.
        • et al.
        Regional left ventricular electrical activation and peak contraction are closely related in candidates for cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2017; 3: 854-862
        • Rickard J.
        • Jackson K.
        • Biffi M.
        • et al.
        The ECG Belt for CRT response trial: design and clinical protocol.
        Pacing Clin Electrophysiol. 2020; 43: 1063-1071
        • Gold M.R.
        • Singh J.P.
        • Ellenbogen K.A.
        • et al.
        Interventricular electrical delay is predictive of response to cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2016; 2: 438-447
        • Koerber S.M.
        • Field M.E.
        • Cobb D.B.
        • et al.
        Electrical delays in quadripolar leads with cardiac resynchronization therapy.
        J Cardiovasc Electrophysiol. 2021; 32: 2498-2503
        • Yu C.M.
        • Bleeker G.B.
        • Fung J.W.
        • et al.
        Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.
        Circulation. 2005; 112: 1580-1586
        • Mullens W.
        • Auricchio A.
        • Martens P.
        • et al.
        Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology.
        Eur J Heart Fail. 2020; 22: 2349-2369
        • Kolias T.J.
        • Aaronson K.D.
        • Armstrong W.F.
        Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure.
        J Am Coll Cardiol. 2000; 36: 1594-1599
        • Molhoek S.G.
        • VAN Erven L.
        • Bootsma M.
        • et al.
        QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure.
        Pacing Clin Electrophysiol. 2004; 27: 308-313
        • Zanon F.
        • Baracca E.
        • Pastore G.
        • et al.
        Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
        Circ Arrhythm Electrophysiol. 2014; 7: 377-383
        • van Everdingen W.M.
        • Zweerink A.
        • Cramer M.J.
        • et al.
        Can we use the intrinsic left ventricular delay (QLV) to optimize the pacing configuration for cardiac resynchronization therapy with a quadripolar left ventricular lead?.
        Circ Arrhythm Electrophysiol. 2018; 11: e005912
        • Ellenbogen K.A.
        • Gold M.R.
        • Meyer T.E.
        • et al.
        Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
        Circulation. 2010; 122: 2660-2668
        • Yagishita D.
        • Shoda M.
        • Yagishita Y.
        • et al.
        Time interval from left ventricular stimulation to QRS onset is a novel predictor of nonresponse to cardiac resynchronization therapy.
        Heart Rhythm. 2019; 16: 395-402
        • Kandala J.
        • Upadhyay G.A.
        • Altman R.K.
        • et al.
        QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy.
        Eur Heart J. 2013; 34: 2252-2262
        • Singh J.P.
        • Berger R.D.
        • Doshi R.N.
        • et al.
        Targeted left ventricular lead implantation strategy for non-left bundle branch block patients: the ENHANCE CRT study.
        JACC Clin Electrophysiol. 2020; 6: 1171-1181
        • Roubicek T.
        • Wichterle D.
        • Kucera P.
        • et al.
        Left ventricular lead electrical delay is a predictor of mortality in patients with cardiac resynchronization therapy.
        Circ Arrhythm Electrophysiol. 2015; 8: 1113-1121
        • Gold M.R.
        • Auricchio A.
        • Leclercq C.
        • et al.
        The rationale and design of the SMART CRT trial.
        Pacing Clin Electrophysiol. 2018; 41: 1212-1216
        • Gold M.R.
        • Yu Y.
        • Singh J.P.
        • et al.
        Effect of interventricular electrical delay on atrioventricular optimization for cardiac resynchronization therapy.
        Circ Arrhythm Electrophysiol. 2018; 11: e006055
        • Gold M.R.
        • Yu Y.
        • Singh J.P.
        • et al.
        The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.
        Heart Rhythm. 2013; 10: 988-993